| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
8e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |